Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion type Assertion NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_head.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion description "[Alterations in P16ink4 or in the gene encoding one of its ligands, cyclin-dependent kinase 4 (CDK4), have been reported in human glioma cell lines and primary tumors but not in primitive neuroectodermal tumors (PNETs), the most common malignant brain tumor of childhood.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_provenance.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion evidence source_evidence_literature NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_provenance.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion SIO_000772 8847566 NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_provenance.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion wasDerivedFrom befree-2016 NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_provenance.
- NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_assertion wasGeneratedBy ECO_0000203 NP1359469.RAA2ui2f0Lu4OD6lCe1F4XGKF0o-1xzHKZtEVNLVnpQc8130_provenance.